Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice

References

• Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics – 2011 update: A report from the American Heart Association. Circulation. 2011;123:e18–e209.
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens. 2009; 27:2121–2158.
   PubMed Web of Science ®Google Scholar
• Kiss I. A hypertoniabetegség felnőttkori és gyermekkori kezelésének szakmai és szervezeti irányelvei. Hypertonia és Nephrologia. 2009;13:81–168.
   Google Scholar
• Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461–1464.
   PubMed Web of Science ®Google Scholar
• Farsang C, Naditch-Brule L, Avogaro A, Ostergren J, Verdecchia P, Maggioni A, et al. Where are we with the management of hypertension? From science to clinical practice. J Clin Hypertens (Greenwich). 2009;11:66–73.
   PubMed Web of Science ®Google Scholar
• Mourad JJ, Waeber B, Zannad F, Laville M, Duru G, Andrejak M. Comparison of different therapeutic strategies in hypertension: A low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens. 2004;22:2379–2386.
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898.
   PubMed Web of Science ®Google Scholar
• Mogensen CE, Viberti G, Halimi S, Ritz E, Ruilope L, Jermendy G, et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: Preterax in albuminuria regression: PREMIER. Hypertension. 2003;41:1063–1071.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Gosse P, Gueret P, Dubourg O, de Simone G, Schmieder R, et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: The PICXEL study. J Hypertens. 2005;23:2063–2070.
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet. 2007;370: 829–840.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Shahane A, Parkar S, Messerli FH. Compliance and fixed-dose combination therapy. Curr Hypertens Rep. 2007;9:184–189.
   PubMed Web of Science ®Google Scholar
• Mourad JJ, Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients. Curr Med Res Opin. 2009;25:2271–2280.
   PubMed Web of Science ®Google Scholar
• Myers MG, Asmar R, Leenen FH, Safar M. Fixed low-dose combination therapy in hypertension – A dose response study of perindopril and indapamide. J Hypertens. 2000;18:317–325.
   PubMed Web of Science ®Google Scholar
• Kang S, Wu YF, An N, Ren M. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril–indapamide combination as first-line treatment of hypertension. Clin Ther. 2004;26:257–270.
   PubMed Web of Science ®Google Scholar
• Pella D. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: Results of the FALCO FORTE programme. High Blood Press Cardiovasc Prev. 2011;18: 107–113.
   PubMedGoogle Scholar
• Coverex-AS Komb Forte filmtabletta. Summary of product characteristics. EGIS Gyógyszergyár Nyrt. 2009.
   Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O’Brien E, Duprez D, et al. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: The REASON study. Am J Hypertens. 2004;17:245–251.
   PubMed Web of Science ®Google Scholar
• Kuo SW, Pei D, Hung YJ, Hsieh AT, Wu LY, Hsieh CH, et al. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Am J Hypertens. 2003;16: 623–628.
   PubMed Web of Science ®Google Scholar
• Madkour H, Gadallah M, Riveline B, Plante GE, Massry SG. Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. Am J Nephrol. 1995;15:251–255.
   PubMed Web of Science ®Google Scholar
• Bakris G, Molitch M, Zhou Q, Sarafidis P, Champion A, Bacher P, et al. Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: Results of the STAR-LET study. J Cardiometab Syndr. 2008;3:18–25.
   PubMedGoogle Scholar
• Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA. 2003;290:2805–2816.
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre. Hypertension. Clinical management of primary hypertension in adults (NICE clinical guideline 127). London, United Kingdom. 2011.
   Google Scholar
• Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet. 2004;363:2049–2051.
   PubMed Web of Science ®Google Scholar